Skip to content

Clinical trials

Phase 2/3 Hematologic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 2/3 Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20101
20141
20182
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated2
Baxalta now part of Shire1
Masonic Cancer Center, University of Minnesota1
National Institute of Allergy and Infectious Diseases (NIAID)1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases6
Hemoglobinopathies2
Anemia, Refractory, with Excess of Blasts1
Anemia, Sickle Cell1
Blood Coagulation Disorders1
Chediak-Higashi Syndrome1
Coagulation Protein Disorders1
Eosinophilia1
Eosinophilic Esophagitis1
Genetic Diseases, Inborn1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.